Tumor-field predominant bullous pemphigoid in a patient with metastatic melanoma

Clicks: 1
ID: 316504
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #154 of 172 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 172 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Bullous pemphigoid (BP) has increasingly been reported in melanoma patients, particularly in association with modern oncologic therapies. We describe a case of BP strikingly confined to the cutaneous field harboring the primary melanoma and in-transit metastases following sequential immune checkpoint inhibition and BRAF/MEK targeted therapy. This tumor-field–restricted pattern highlights a possible spatial link between melanoma biology, local immune dysregulation, and BP pathogenesis.
Reference Key
openalex_W7164061269 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alessia Caligiure, Endrio Kaja, Alba Guglielmo, Arianna De Martino, Sebastiano Posenato, Lucia Mantovani, Aikaterini Kalpaktsoglou, Roberta Gafà, Massimo Guidoboni, Alessandro Borghi
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag243
URL
https://doi.org/10.1093/ced/llag243
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.